LegoChem Biosciences Inc (141080) — Capital Reinvestment Ratio

Latest as of December 2024: 0.07x

LegoChem Biosciences Inc (141080) has a Capital Reinvestment Ratio of 0.07x as of December 2024, meaning it reinvests 0% of its operating cash flow (₩78.48 Billion) in capital expenditures (₩5.70 Billion). See LegoChem Biosciences Inc (141080) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.07x

Capex / Operating Cash Flow

Operating Cash Flow

₩78.48 Billion

KRW

Capital Expenditures

₩5.70 Billion

KRW

Data as of

Dec 2024

Most recent filing

LegoChem Biosciences Inc Capital Reinvestment Ratio (2019–2024)

This chart tracks LegoChem Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods. Check 141080 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for LegoChem Biosciences Inc (2019–2024)

Year-by-year Capital Reinvestment Ratio for LegoChem Biosciences Inc from 2019 to 2024. For live market cap and broader valuation context, see market cap of LegoChem Biosciences Inc.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change
2024	0.07x	₩78.48 Billion	₩5.70 Billion	▼ -48.0%
2019	0.14x	₩24.11 Billion	₩3.37 Billion	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow